text
"['\nX. 대주주 등과의 거래내용\n(1) 당분기 및 전분기 중 회사와 매출 등 거래 또는 채권, 채무 잔액이 있는 특수관계자 현황은 다음과 같습니다.\n관 계\n회 \xa0 \xa0 사 \xa0 \xa0 명\n종속기업\n㈜유한화학 , ㈜유한메디카, ㈜와이즈메디, ㈜유한건강생활, YUHAN USA CORPORATION, YUHAN UZBEKISTAN, 애드파마㈜, YUHAN ANZ Pty Ltd., ㈜에이투젠, ㈜이뮨온시아, 에스비바이오팜㈜, 암호명케이문화산업전문(유),퍼멘텍㈜, ㈜코스온\n관계기업 및 공동기업\n유한킴벌리㈜, ㈜유한크로락스, ㈜한국얀센, ㈜유칼릭스, ㈜엔솔바이오사이언스, ㈜씨.앤.씨, ㈜휴이노, ㈜메디오젠,㈜제이인츠바이오, 메디라마㈜, ㈜프로젠, ㈜메리츠-수성글로벌바이오제1호,\xa0㈜에스엘바이젠\r\n기타특수관계자\n류신(칭다오)건강(유), (재)유한재단, ㈜리드팜, 주식회사 유, ㈜애니힐\n(2) 당분기 및 전분기 중 특수관계자와의 거래 내역은 다음과 같습니다.\n- 당분기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익 등)\n배당금수익\n매입 등\n기타매입\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n종속기업 :\n\xa0㈜유한화학\xa0\n2,880\n8,640\n-\n-\n-\n-\n-\n-\n47,472,563\n166,054,246\n-\n-\n\xa0㈜유한메디카\n-\n218\n6,900\n20,700\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0㈜와이즈메디\n-\n-\n8,970\n26,910\n-\n-\n-\n-\n4,984,819\n15,555,711\n-\n-\n\xa0㈜유한건강생활\n-\n-\n14,340\n44,220\n-\n5,270\n-\n-\n35,678\n2,404,319\n-\n-\n\xa0애드파마㈜\n-\n-\n-\n143,236\n-\n-\n-\n-\n6,506,005\n17,306,636\n-\n-\n\xa0㈜에이투젠\n-\n-\n-\n-\n-\n-\n-\n-\n2,303,149\n5,389,153\n-\n-\n\xa0에스비바이오팜㈜\n-\n-\n66,000\n201,600\n1,075\n3,227\n-\n-\n1,048,166\n2,908,686\n-\n31,258\n\xa0㈜이뮨온시아\n-\n-\n936\n2,808\n-\n198,524\n-\n-\n1,742,197\n3,068,003\n-\n-\n소 계\n2,880\n8,858\n97,146\n439,474\n1,075\n207,021\n-\n-\n64,092,577\n212,686,754\n-\n31,258\n관계기업 및 공동기업 :\n\xa0유한킴벌리㈜\n-\n-\n-\n-\n-\n-\n-\n25,500,000\n-\n17,047\n-\n-\n\xa0㈜유한크로락스\n-\n-\n449,778\n1,191,483\n2,301,916\n5,708,896\n-\n2,198,000\n28,038,032\n68,869,142\n-\n-\n\xa0㈜한국얀센\n-\n-\n-\n-\n-\n-\n-\n3,113,654\n9,756,933\n30,324,199\n-\n-\n\xa0㈜유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n21,712\n64,698\n-\n-\n\xa0㈜엔솔바이오사이언스\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n1,500,000\n\xa0㈜워랜텍(*)\n-\n-\n-\n-\n-\n771,712\n-\n-\n-\n95,877\n-\n-\n\xa0㈜씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,623,027\n4,269,379\n-\n-\n\xa0㈜휴이노\n-\n-\n-\n-\n-\n-\n-\n-\n1,326,500\n3,293,750\n-\n-\n\xa0㈜메디오젠\n-\n-\n-\n-\n-\n-\n-\n-\n427,669\n910,610\n-\n-\n\xa0㈜제이인츠바이오\n-\n-\n-\n-\n-\n-\n-\n-\n2,822,050\n5,822,050\n-\n-\n\xa0메디라마㈜\n-\n-\n22,168\n66,506\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0㈜프로젠\n-\n-\n-\n-\n-\n-\n-\n-\n510,245\n510,245\n-\n-\n소 계\n-\n-\n471,946\n1,257,989\n2,301,916\n6,480,608\n-\n30,852,454\n44,526,168\n114,176,997\n-\n1,500,000\n기타특수관계자\xa0:\n\xa0(재)유한재단\n-\n-\n4,278\n12,834\n-\n-\n-\n-\n-\n-\n2,500,000\n3,500,000\n\xa0주식회사 유\n-\n-\n-\n-\n-\n-\n-\n-\n16,059\n48,124\n-\n-\n\xa0㈜애니힐\n-\n-\n-\n-\n-\n-\n-\n-\n10,618\n74,298\n-\n-\n\xa0㈜리드팜\n518,347\n1,900,120\n-\n-\n-\n-\n-\n-\n926\n2,386\n-\n-\n소 계\n518,347\n1,900,120\n4,278\n12,834\n-\n-\n-\n-\n27,603\n124,808\n2,500,000\n3,500,000\n합 계\n521,227\n1,908,978\n573,370\n1,710,297\n2,302,991\n6,687,629\n-\n30,852,454\n108,646,348\n326,988,559\n2,500,000\n5,031,258\n(*) 당분기 중 매각이 완료되기 전까지의 거래내역입니다.\n- 전분기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익등)\n배당금수익\n매입등\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n종속기업 :\n\xa0㈜유한화학\xa0\n1,800\n7,200\n-\n-\n-\n-\n-\n-\n38,779,749\n144,462,878\n\xa0㈜유한메디카\n-\n218\n6,900\n132,454\n-\n-\n-\n-\n-\n-\n\xa0㈜와이즈메디\n-\n-\n8,970\n26,910\n-\n-\n-\n-\n5,519,532\n14,899,127\n\xa0㈜유한건강생활\n-\n-\n184,683\n606,100\n3,106\n3,106\n-\n-\n1,637,395\n5,856,371\n\xa0애드파마㈜\n-\n-\n273,423\n276,543\n-\n-\n-\n-\n5,009,912\n8,460,969\n\xa0㈜에이투젠\n-\n-\n-\n-\n-\n-\n-\n-\n1,961,456\n2,757,186\n소 계\n1,800\n7,418\n473,976\n1,042,007\n3,106\n3,106\n-\n-\n52,908,044\n176,436,531\n관계기업 및 공동기업 :\n\xa0㈜유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n21,662\n64,825\n\xa0㈜유한크로락스\n-\n2,755\n381,346\n1,154,231\n2,050,644\n4,049,955\n-\n1,868,300\n24,900,178\n60,954,475\n\xa0유한킴벌리㈜\n-\n-\n-\n-\n-\n-\n-\n20,700,000\n-\n-\n\xa0㈜한국얀센\n-\n-\n-\n62,442\n-\n-\n-\n5,529,000\n10,280,385\n31,293,186\n\xa0㈜이뮨온시아\n-\n-\n936\n2,808\n-\n-\n-\n-\n-\n-\n\xa0파라투스에스피사모투자(합)(*)\n-\n-\n-\n-\n-\n-\n-\n6,631,427\n-\n30,029,960\n\xa0㈜씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,083,521\n4,549,692\n\xa0㈜워랜텍\n-\n3,680\n-\n-\n-\n-\n-\n-\n92,619\n2,053,321\n\xa0㈜지아이이노베이션\n-\n-\n-\n-\n464,500\n4,098,000\n-\n-\n-\n-\n\xa0㈜휴이노\n-\n-\n-\n-\n-\n-\n-\n-\n(1,724,565)\n(1,737,315)\n\xa0㈜메디오젠\n-\n-\n-\n-\n-\n-\n-\n11,728\n523,006\n1,555,564\n\xa0에스비바이오팜㈜\n-\n-\n76,800\n230,400\n-\n1,300\n-\n-\n870,351\n2,232,173\n\xa0메디라마㈜\n-\n-\n21,987\n66,161\n-\n-\n-\n-\n-\n20,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n-\n6,435\n481,069\n1,516,042\n2,515,144\n8,149,255\n-\n34,781,255\n36,047,157\n131,015,881\n기타특수관계자 :\n\xa0㈜리드팜\n1,058,081\n2,236,138\n-\n-\n-\n-\n-\n-\n785\n1,777\n\xa0류신(칭다오)건강(유)\n-\n-\n-\n-\n-\n-\n-\n-\n10\n121\n(재)유한재단\n-\n-\n4,706\n12,834\n-\n-\n-\n-\n-\n-\n소 계\n1,058,081\n2,236,138\n4,706\n12,834\n-\n-\n-\n-\n795\n1,898\n합 계\n1,059,881\n2,249,991\n959,751\n2,570,883\n2,518,250\n8,152,361\n-\n34,781,255\n88,955,996\n307,454,310\n(*) 관계기업에 제외되기 전까지의 거래내역입니다.\n(3) 당분기말과 전기말 현재 특수관계자와의 채권ㆍ채무는 다음과 같습니다.\n\xa0(단위:천원)\n회사명\n매출채권\n매입채무\n미수금 등 기타자산\n예수보증금\n대여금\n당분기말\n전기말\n당분기말\n전기말\n당분기말\n전기말\n당분기말\n전기말\n당분기말\n전기말\n종속기업 :\n\xa0㈜유한화학\xa0\n-\n1,980\n26,477,303\n3,735,203\n-\n9,900,971\n-\n-\n-\n-\n\xa0㈜유한메디카\n-\n-\n-\n-\n-\n-\n400,000\n400,000\n-\n-\n\xa0㈜와이즈메디\n-\n-\n3,478,808\n3,405,379\n1,400,000\n1,400,000\n520,000\n520,000\n-\n-\n\xa0㈜유한건강생활\n4,818\n5,478\n4,210\n999,163\n-\n-\n700,800\n796,800\n-\n-\n\xa0YUHAN UZBEKISTAN\n753,364\n736,123\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0애드파마㈜\n-\n-\n-\n1,634,408\n732,022\n2,492,082\n-\n-\n-\n-\n\xa0㈜에이투젠\n-\n-\n458,176\n1,107,634\n-\n-\n-\n-\n-\n-\n\xa0㈜이뮨온시아\n343\n-\n1,916,416\n-\n-\n-\n-\n-\n-\n-\n\xa0에스비바이오팜㈜\n-\n-\n-\n-\n11,041,602\n7,745,818\n225,000\n250,000\n93,000\n93,000\n\xa0㈜코스온\n-\n-\n-\n-\n-\n2,043,540\n-\n-\n-\n-\n소 계\n758,525\n743,581\n32,334,913\n10,881,787\n13,173,624\n23,582,411\n1,845,800\n1,966,800\n93,000\n93,000\n관계기업 및 공동기업\xa0:\n\xa0㈜유한크로락스\n494,756\n433,330\n20,094,298\n24,110,868\n1,693,626\n1,438,256\n-\n-\n-\n-\n\xa0㈜한국얀센\n-\n-\n3,526,987\n7,181,019\n-\n-\n-\n-\n-\n-\n\xa0㈜유칼릭스\n-\n-\n4,748\n3,758\n-\n-\n-\n-\n-\n-\n\xa0㈜씨.앤.씨\n-\n-\n935,887\n2,121,987\n-\n-\n-\n-\n-\n-\n\xa0㈜워랜텍\n-\n-\n-\n398,141\n-\n-\n-\n-\n-\n-\n\xa0㈜지아이이노베이션\n-\n-\n-\n-\n-\n1,058,301\n-\n-\n-\n-\n\xa0㈜휴이노\n-\n-\n302,500\n275,000\n-\n-\n-\n-\n-\n-\n\xa0㈜메디오젠\n-\n-\n258,032\n694,931\n-\n-\n-\n-\n-\n-\n\xa0메디라마㈜\n8,062\n-\n-\n-\n100\n-\n42,000\n42,000\n-\n-\n소 계\n502,818\n433,330\n25,122,452\n34,785,704\n1,693,726\n2,496,557\n42,000\n42,000\n-\n-\n기타특수관계자\xa0:\n\xa0(재)유한재단\n-\n-\n-\n-\n-\n-\n248,000\n248,000\n-\n-\n\xa0㈜리드팜\n240,183\n391,291\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0주식회사 유\n-\n-\n4,612\n1,485\n-\n-\n-\n-\n-\n-\n\xa0㈜애니힐\n-\n-\n11,679\n12,595\n-\n-\n-\n-\n-\n-\n소 계\n240,183\n391,291\n16,291\n14,080\n-\n-\n248,000\n248,000\n-\n-\n합 계\n1,501,526\n1,568,202\n57,473,656\n45,681,571\n14,867,350\n26,078,968\n2,135,800\n2,256,800\n93,000\n93,000\n(4) 당분기 및 전분기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.\n(단위: 천원)\n특수관계 구분\n회사명\n당분기\n전분기\n회수\n출자\n대여\n출자\xa0\n종속기업\n㈜에이투젠\n-\n5,000,008\n-\n7,000,069\nYUHAN USA CORPORATION\n-\n3,911,400\n-\n-\n에스비바이오팜㈜\n-\n7,742,202\n93,000\n-\nYUHAN ANZ Pty Ltd.\n-\n321,325\n-\n302,671\n암호명케이문화산업전문(유)\xa0\n-\n2,000,000\n-\n-\n퍼멘텍㈜\n-\n-\n-\n5,747,000\n㈜코스온\n-\n5,541,363\n2,000,000\n-\n관계기업 및 공동기업\n㈜제이인츠바이오\n-\n-\n-\n1,999,996\n메디라마㈜\n-\n-\n-\n1,499,971\n㈜메디오젠\n4,925,020\n-\n-\n-\n㈜프로젠\n-\n6,000,003\n-\n29,998,329\n㈜메리츠-수성 글로벌바이오제1호\n-\n-\n-\n2,000,000\n주식회사 에스엘바이젠\n-\n752,653\n-\n-\n(5) 당분기말 현재 회사가 특수관계자에게 제공한 지급보증 및 담보 내역은 다음과 같습니다.\n(단위: 천원)\n회사명\n보증 등의 내용\n금융기관\n보증 금액\n종속기업\xa0:\n㈜유한건강생활\n일반대출\n신한은행\n3,600,000\n애드파마㈜\n운전자금대출\n하나은행\n6,000,000\n㈜코스온\n지급보증보험\nSGI서울보증\n898,272\n합 \xa0계\n10,498,272\n(6) 회사는 등기이사 및 회사 기업활동의 계획, 운영 및 통제에 대한 중요한 권한과 책임을 가진 등기 임원을 주요 경영진으로 판단하고 있으며, 당분기 및 전분기 중 주요 경영진에 대한 보상금액은 다음과 같습니다.\n(단위:천원)\n구 \xa0분\n당분기\n전분기\n3개월\n누적\n3개월\n누적\n단기종업원급여\n707,020\n1,691,160\n639,478\n1,758,281\n퇴직급여\n104,973\n254,256\n72,558\n217,675\n합 계\n811,993\n1,945,416\n712,036\n1,975,956\n']"
